US Stock MarketDetailed Quotes
ALDX Aldeyra Therapeutics
- 6.260
- +0.070+1.13%
Trading Sep 13 10:00 ET
371.98MMarket Cap-9781P/E (TTM)
6.360High6.210Low7.81KVolume6.280Open6.190Pre Close49.12KTurnover0.02%Turnover RatioLossP/E (Static)59.42MShares6.74052wk High3.78P/B270.00MFloat Cap1.42052wk Low--Dividend TTM43.13MShs Float16.700Historical High--Div YieldTTM2.42%Amplitude1.420Historical Low6.289Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Aldeyra Therapeutics Stock Forum
NEWS
Aldeyra Therapeutics Enrolls First Patient in Phase 3 Clinical Trial Designed to Enable Potential Resubmission of New Drug Application of Reproxalap in Dry Eye Disease
Positive
Enrollment of the first patient in the Phase 3 clinical trial for reproxalap indicates progress in Aldeyra Therapeutics' efforts to address dry eye disease.
Potential resubmission of the NDA for reproxalap in the second half of 2024 demonstrates the company's commitment to advancing in...
Grabar Law Office is investigating claims on behalf of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) shareholders. The investigation concerns whether certain officers of Aldeyra have breached their fiduciary duties owed to the company.
Current Aldeyra shareholders who have continuously held Aldeyra shares since prior to Januar...
No comment yet